Visby Medical
Founded Year
2012Stage
Series E - II | AliveTotal Raised
$369.13MValuation
$0000Last Raised
$35M | 1 yr agoAbout Visby Medical
Visby Medical develops polymerase chain reaction (PCR) based diagnostic tests for the detection of infectious diseases. The company offers medical solutions for sexual health tests, respiratory health tests, and other infectious diseases such as covid-19, chlamydia, gonorrhea, and trichomonas. It was formerly known as Click Diagnostics. The company was founded in 2012 and is based in San Jose, California.
Missing: Visby Medical's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Visby Medical's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Visby Medical
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Visby Medical is included in 5 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,214 items
Medical Devices
11,963 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health Monitoring & Diagnostics
3,531 items
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Health IT
7,901 items
Clinical Encounter Tech
899 items
Visby Medical Patents
Visby Medical has filed 34 patents.
The 3 most popular patent topics include:
- Medical tests
- Molecular biology
- Blood tests
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
5/25/2021 | 12/20/2022 | Cooking appliances, Home appliances, Heating, Heat conduction, Heaters | Grant |
Application Date | 5/25/2021 |
|---|---|
Grant Date | 12/20/2022 |
Title | |
Related Topics | Cooking appliances, Home appliances, Heating, Heat conduction, Heaters |
Status | Grant |
Latest Visby Medical News
Apr 18, 2023
4.2.1 What's Wrong with Microbiology 4.2.2 The Features Battleground of Infectious Disease Diagnostics 4.2.3 Multiplex vs. POC/Rapid 4.2.5 From Multiple Pathogens to All Pathogens - The Next Next Generation 4.2.6 Gene Sequence Diagnostics WITHOUT the Sequencing. 4.2.7 Markers of Resistance. 5 Antibiotic Resistance Diagnostics Recent Developments 5.1 Antibiotic Resistance Recent Developments 5.1.1 Importance of These Developments 5.1.2 How to Use This Section 5.2 FDA Clears New bioMerieux Diagnostic System and Panel 5.3 Selux Diagnostics Phenotyping System Gets FDA Approval 5.4 New diagnostics to tackle drug resistant infections 5.5 Takara Bio USA, Inc. and BioExcel Diagnostics Partner for Infectious Disease Panels 5.6 Three companies join forces to tackle antimicrobial resistance (AMR) 5.7 T2 Biosystems Exercises BARDA Option 5.8 OpGen to Ramp up Use of Acuitas AMR Gene Panel 5.9 BD Partners With Pfizer, Wellcome to Study AMR Dx 5.10 Sepsis Test Developers Accelerate Plans 5.11 OpGen Receives FDA Clearance for AMR Panel 5.12 Visby Medical - Rapid Uptake of Handheld PCR Test for STIs 5.13 MicroGenDx, OrthoKey Clinic and OrthoKey Surgery 5.14 BioMerieux Receives CE Mark for Vitek Clinical Microbiology System 5.15 Hologic to Acquire Mobidiag 5.16 Campylobacter strains exchange genes 5.17 Disinfection spreads antimicrobial resistance 5.18 Molzym, Fraunhofer Developing Rapid Sepsis Dx 5.19 Illumina, IDbyDNA Build NGS-Based Respiratory Panel 5.20 Accelerate Diagnostics Expands AMR Testing 5.21 Rapid diagnostics linked to optimal antibiotics 5.22 Visby Medical Wins AMR Diagnostic Competition 5.23 DNAe Technology SARS-CoV-2 Sequences 5.24 Infections with foodborne bacteria becoming harder to treat 5.25 Dust is sharing antibiotic resistance genes 6 Key AMR Diagnostics Companies 6.1 1928 Diagnostics
Visby Medical Frequently Asked Questions (FAQ)
When was Visby Medical founded?
Visby Medical was founded in 2012.
Where is Visby Medical's headquarters?
Visby Medical's headquarters is located at 3010 North First Street, San Jose.
What is Visby Medical's latest funding round?
Visby Medical's latest funding round is Series E - II.
How much did Visby Medical raise?
Visby Medical raised a total of $369.13M.
Who are the investors of Visby Medical?
Investors of Visby Medical include Pitango Venture Capital, Artiman Ventures, John Doerr, +ND Capital, Blue Water Life Science Advisors and 15 more.
Who are Visby Medical's competitors?
Competitors of Visby Medical include Sense Biodetection and 1 more.
Compare Visby Medical to Competitors
bioMerieux (EPA: BIM), operates within the field of in vitro diagnostics and provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. The company's products are used for diagnosing infectious diseases and providing medical value results for cancer screening, monitoring, and cardiovascular emergencies. It was founded in 1963 and is based in Marcy-L'Etoile, France.
Nostics develops a nanotechnology-based instant diagnostics platform. The company's platform provides instant test results and cloud-based digital diagnostics solutions. It is based in Amsterdam, Netherlands.
Oxford Nanopore Technologies develops a nanopore DNA sequencer, the MinION. The MinION is a portable, real-time, long-read, low-cost device that has been designed to bring easy biological analyses to anyone, whether in scientific research, education or a range of real world applications such as disease/pathogen surveillance, environmental monitoring, food chain surveillance, self-quantification or even microgravity biology.
Abbott (NYSE: ABT) operates as a global healthcare company. It provides a portfolio of science-based offerings in diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. It was founded in 1894 and is based in Abbott Park, Illinois.
Thermo Fisher Scientific provides a broad range of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics applications. The company's portfolio of services includes technologies for mass spectrometry, elemental analysis, molecular spectroscopy, sample preparation, informatics, fine and high-purity chemistry production, cell culture, ribonucleic acid (RNA) interference analysis, and immunodiagnostic testing. It was founded in 1956 and is based in Waltham, Massachusetts.
Cue Health (NASDAQ: HLTH) develops and manufactures consumer and professional medical diagnostic products that are designed to be used in the clinical setting and in the at-home settings, where appropriate. Cue’s mission is to create tools that empower physicians and consumers by increasing their access to their own health data. The Cue Health Monitoring System is a platform that provides rapid diagnostic information to clinicians and patients seeking to benefit from a connected healthcare delivery ecosystem.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.